LRRK2 and Parkinson disease: A study of network abnormalities among non-manifesting PD related to gene Leucine Rich Repeat Kinase 2 (LRRK2) mutation carriers displayed significant non-motor cerebral changes among populations “at risk” for future development of PD [27].